Last update:

Oncology & Cancer news

Oncology & Cancer

New insights into how the drug pomalidomide fights cancer

Multiple myeloma is a cancer of the white blood cells, and patients diagnosed with this disease commonly die within five years. Clinicians often treat multiple myeloma with the drug thalidomide and structurally similar drugs ...

Oncology & Cancer

Increasing the effectiveness of cancer treatments: Anti-PD-L1 immunotherapy

For most people, there is no scarier diagnosis than that of cancer. While treatments including chemotherapy and radiotherapy have been used since the 1940s and late 1800s, respectively, immunotherapy has more recently emerged ...

Oncology & Cancer

Obesity increases endometrial cancer risk

Endometrial cancer, which begins in the uterus within the layer of cells that form the uterine lining, has been on the rise over the past decade. Each year in the U.S., over 60,000 women are diagnosed with endometrial cancer, ...

Oncology & Cancer

Cancer survivors urgently need better nutritional support

More than two-thirds (69 percent) of the colorectal cancer patients who took part in the national survey said they did not receive any nutritional advice or support from their healthcare team throughout diagnosis, treatment ...

Oncology & Cancer

Breast cancer drug set to transform prostate cancer treatment

A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer and should become a new standard treatment for the disease, concludes a major trial which is set to change clinical practice.

Oncology & Cancer

Increasing the effectiveness of immunotherapy against skin cancer

The melanoma is a malignant tumor of the pigment cells. If diagnosed early, the tumor can be removed completely—and the chances of recovery are good. But in later stages, when the tumor has already spread or formed metastases ...

Oncology & Cancer

Immunotherapy improves survival in advanced bladder cancer patients

An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Queen Mary University ...